|
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Avaliação DCF
CN | Healthcare | Medical - Pharmaceuticals | SHH
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Bundle
Obtenha uma visão da sua análise de avaliação da Yifeng Pharmacy Chain Co., Ltd. (603939SS) usando nossa calculadora DCF de última geração! Equipado com dados reais (603939Ss), este modelo do Excel permite ajustar as previsões e suposições para determinar com precisão o valor intrínseco da Yifeng Pharmacy Chain Co., Ltd.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,276.2 | 13,144.5 | 15,326.3 | 19,886.4 | 22,588.2 | 22,983.9 | 23,386.6 | 23,796.3 | 24,213.2 | 24,637.4 |
| Revenue Growth, % | 0 | 27.91 | 16.6 | 29.75 | 13.59 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
| EBITDA | 954.8 | 2,147.8 | 2,698.4 | 3,642.0 | 3,846.9 | 3,612.3 | 3,675.6 | 3,740.0 | 3,805.5 | 3,872.1 |
| EBITDA, % | 9.29 | 16.34 | 17.61 | 18.31 | 17.03 | 15.72 | 15.72 | 15.72 | 15.72 | 15.72 |
| Depreciation | 190.5 | 1,039.3 | 1,308.7 | 1,586.5 | 1,831.8 | 1,580.7 | 1,608.3 | 1,636.5 | 1,665.2 | 1,694.4 |
| Depreciation, % | 1.85 | 7.91 | 8.54 | 7.98 | 8.11 | 6.88 | 6.88 | 6.88 | 6.88 | 6.88 |
| EBIT | 764.3 | 1,108.6 | 1,389.7 | 2,055.5 | 2,015.1 | 2,031.6 | 2,067.2 | 2,103.4 | 2,140.3 | 2,177.8 |
| EBIT, % | 7.44 | 8.43 | 9.07 | 10.34 | 8.92 | 8.84 | 8.84 | 8.84 | 8.84 | 8.84 |
| Total Cash | 1,617.7 | 4,105.0 | 3,072.8 | 4,162.6 | 5,196.6 | 5,100.6 | 5,189.9 | 5,280.8 | 5,373.4 | 5,467.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 751.0 | 831.2 | 1,087.1 | 2,528.9 | 2,150.2 | 1,974.8 | 2,009.4 | 2,044.6 | 2,080.4 | 2,116.8 |
| Account Receivables, % | 7.31 | 6.32 | 7.09 | 12.72 | 9.52 | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 |
| Inventories | 1,820.6 | 2,172.2 | 3,040.6 | 3,614.5 | 3,808.0 | 4,096.4 | 4,168.2 | 4,241.2 | 4,315.5 | 4,391.1 |
| Inventories, % | 17.72 | 16.53 | 19.84 | 18.18 | 16.86 | 17.82 | 17.82 | 17.82 | 17.82 | 17.82 |
| Accounts Payable | 3,018.9 | 3,822.0 | 4,805.5 | 6,760.7 | 1,955.6 | 6,089.0 | 6,195.7 | 6,304.3 | 6,414.7 | 6,527.1 |
| Accounts Payable, % | 29.38 | 29.08 | 31.35 | 34 | 8.66 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 |
| Capital Expenditure | -454.0 | -582.8 | -827.5 | -587.5 | -739.9 | -941.5 | -958.0 | -974.8 | -991.9 | -1,009.2 |
| Capital Expenditure, % | -4.42 | -4.43 | -5.4 | -2.95 | -3.28 | -4.1 | -4.1 | -4.1 | -4.1 | -4.1 |
| Tax Rate, % | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 |
| EBITAT | 510.4 | 708.2 | 922.3 | 1,381.5 | 1,396.4 | 1,355.2 | 1,378.9 | 1,403.1 | 1,427.7 | 1,452.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 694.1 | 1,536.0 | 1,262.6 | 2,319.8 | -2,131.5 | 6,014.7 | 2,029.6 | 2,065.2 | 2,101.3 | 2,138.2 |
| WACC, % | 5.87 | 5.86 | 5.87 | 5.87 | 5.88 | 5.87 | 5.87 | 5.87 | 5.87 | 5.87 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 12,512.7 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 2,213 | |||||||||
| Terminal Value | 93,388 | |||||||||
| Present Terminal Value | 70,216 | |||||||||
| Enterprise Value | 82,728 | |||||||||
| Net Debt | 6,489 | |||||||||
| Equity Value | 76,239 | |||||||||
| Diluted Shares Outstanding, MM | 1,210 | |||||||||
| Equity Value Per Share | 63.01 |
What You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled financial data for Yifeng Pharmacy Chain Co., Ltd. (603939SS).
- Accurate Market Data: Access to historical figures and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA margin, and WACC to suit your analysis.
- Instant Calculations: Observe immediate changes in Yifeng’s valuation based on your input modifications.
- Professional Resource: Designed for investors, financial directors, consultants, and financial analysts.
- Intuitive Layout: Organized for straightforward navigation and usability, complete with step-by-step guidance.
Key Features
- Pre-Loaded Data: Yifeng Pharmacy Chain's historical financial reports and pre-filled forecasts.
- Fully Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Instantly view Yifeng Pharmacy Chain's intrinsic value recalculating live.
- Intuitive Visual Outputs: Dashboard charts illustrate valuation outcomes and critical metrics.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance specialists.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Yifeng Pharmacy DCF Calculator for [603939SS].
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and additional factors.
- Instant Calculations: The model automatically recalculates Yifeng Pharmacy's intrinsic value.
- Test Scenarios: Explore various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial strategies.
Why Choose This Calculator for Yifeng Pharmacy Chain Co., Ltd. (603939SS)?
- Designed for Experts: A sophisticated tool tailored for financial analysts, CFOs, and strategic consultants.
- Comprehensive Data: Yifeng's historical and forecasted financials are preloaded for enhanced precision.
- Dynamic Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Intuitive Outputs: Instantly calculates intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Clear, step-by-step guidance makes the process straightforward.
Who Should Use This Product?
- Individual Investors: Make informed decisions regarding the purchase or sale of Yifeng Pharmacy Chain Co., Ltd. (603939SS) stocks.
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Yifeng Pharmacy Chain Co., Ltd. (603939SS).
- Consultants: Provide clients with timely and precise valuation insights related to Yifeng Pharmacy Chain Co., Ltd. (603939SS).
- Business Owners: Gain a deeper understanding of how large corporations like Yifeng Pharmacy Chain Co., Ltd. (603939SS) are valued to refine your own business strategies.
- Finance Students: Master valuation techniques using real-life data and case studies from Yifeng Pharmacy Chain Co., Ltd. (603939SS).
Contents of the Template
- Comprehensive DCF Model: An editable template featuring in-depth valuation calculations.
- Real-World Data: Yifeng Pharmacy Chain Co., Ltd.'s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions for scenario testing.
- Financial Statements: Detailed annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for evaluating profitability, efficiency, and leverage.
- Dashboard with Visual Outputs: Engaging charts and tables presenting clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.